Current concept and epidemiology of systemic vasculitides

Takayuki Katsuyama, Kenei Sada, Hirofumi Makino

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies.

Original languageEnglish
Pages (from-to)505-513
Number of pages9
JournalAllergology International
Volume63
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Systemic Vasculitis
Epidemiology
Vasculitis
Antineutrophil Cytoplasmic Antibodies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Microscopic Polyangiitis
Takayasu Arteritis
Giant Cell Arteritis
Granulomatosis with Polyangiitis
Incidence
Interstitial Lung Diseases

Keywords

  • Antineutrophil cytoplasmic antibody-associated vasculitis
  • Chapel Hill Consensus Conference nomenclature of systemic vasculitides
  • Epidemiology
  • Large vessel vasculitis
  • Polyarteritis nodosa

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)

Cite this

Current concept and epidemiology of systemic vasculitides. / Katsuyama, Takayuki; Sada, Kenei; Makino, Hirofumi.

In: Allergology International, Vol. 63, No. 4, 2014, p. 505-513.

Research output: Contribution to journalArticle

@article{3cca41a8e7bd40a691e00a4093a6ddeb,
title = "Current concept and epidemiology of systemic vasculitides",
abstract = "Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies.",
keywords = "Antineutrophil cytoplasmic antibody-associated vasculitis, Chapel Hill Consensus Conference nomenclature of systemic vasculitides, Epidemiology, Large vessel vasculitis, Polyarteritis nodosa",
author = "Takayuki Katsuyama and Kenei Sada and Hirofumi Makino",
year = "2014",
doi = "10.2332/allergolint.14-RAI-0778",
language = "English",
volume = "63",
pages = "505--513",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "4",

}

TY - JOUR

T1 - Current concept and epidemiology of systemic vasculitides

AU - Katsuyama, Takayuki

AU - Sada, Kenei

AU - Makino, Hirofumi

PY - 2014

Y1 - 2014

N2 - Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies.

AB - Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies.

KW - Antineutrophil cytoplasmic antibody-associated vasculitis

KW - Chapel Hill Consensus Conference nomenclature of systemic vasculitides

KW - Epidemiology

KW - Large vessel vasculitis

KW - Polyarteritis nodosa

UR - http://www.scopus.com/inward/record.url?scp=84924761869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924761869&partnerID=8YFLogxK

U2 - 10.2332/allergolint.14-RAI-0778

DO - 10.2332/allergolint.14-RAI-0778

M3 - Article

C2 - 25339434

AN - SCOPUS:84924761869

VL - 63

SP - 505

EP - 513

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 4

ER -